Buys | $0 | 0 | 0 |
Sells | $164,783,147 | 128 | 100 |
Chapman Rowan E | director | 0 | $0 | 3 | $1.16M | $-1.16M |
Marcus Gail Boxer | director | 0 | $0 | 4 | $2.71M | $-2.71M |
Baynes Roy D. | director | 0 | $0 | 1 | $5.44M | $-5.44M |
Fesko John | PRESIDENT, CHIEF BUS. OFFICER | 0 | $0 | 14 | $5.52M | $-5.52M |
RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | 0 | $0 | 13 | $9.61M | $-9.61M |
BOTHA ROELOF | director | 0 | $0 | 1 | $14.79M | $-14.79M |
Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 0 | $0 | 16 | $15.37M | $-15.37M |
Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | 0 | $0 | 32 | $16.88M | $-16.88M |
Sheena Jonathan | CO-FOUNDER | 0 | $0 | 19 | $18.36M | $-18.36M |
Rabinowitz Matthew | EXECUTIVE CHAIRMAN | 0 | $0 | 5 | $35.57M | $-35.57M |
Chapman Steven Leonard | CEO AND PRESIDENT | 0 | $0 | 21 | $51.31M | $-51.31M |
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to identify chromosomal anomalies or inherited genetic conditions during an in vitro …
Over the last 12 months, insiders at Natera, Inc. have bought $0 and sold $164.78M worth of Natera, Inc. stock.
On average, over the past 5 years, insiders at Natera, Inc. have bought $3.98M and sold $94.42M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 219,820 shares for transaction amount of $6.32M was made by Rabinowitz Matthew () on 2022‑05‑12.
2025-03-14 | Sale | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | 50,000 0.0369% | $147.71 | $7.39M | +0.35% | |
2025-03-12 | Sale | Marcus Gail Boxer | director | 4,000 0.003% | $147.69 | $590,773 | +0.60% | |
2025-03-05 | Sale | Chapman Steven Leonard | CEO AND PRESIDENT | 87,272 0.0626% | $143.40 | $12.52M | -4.34% | |
2025-03-05 | Sale | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 6,000 0.0043% | $143.29 | $859,734 | -4.34% | |
2025-02-26 | Sale | Sheena Jonathan | CO-FOUNDER | 5,600 0.0042% | $160.47 | $898,609 | -11.49% | |
2025-02-06 | Sale | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | 663 0.0005% | $177.77 | $117,862 | -10.58% | |
2025-02-06 | Sale | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 1,632 0.0012% | $177.77 | $290,121 | -10.58% | |
2025-02-03 | Sale | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | 43,502 0.0329% | $176.88 | $7.69M | -9.46% | |
2025-01-31 | Sale | Sheena Jonathan | CO-FOUNDER | 163 0.0001% | $176.60 | $28,786 | -8.79% | |
2025-01-31 | Sale | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | 2,286 0.0017% | $175.98 | $402,288 | -8.79% | |
2025-01-31 | Sale | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | 1,886 0.0014% | $176.60 | $333,068 | -8.79% | |
2025-01-29 | Sale | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | 6,003 0.0045% | $165.87 | $995,716 | -0.93% | |
2025-01-29 | Sale | Sheena Jonathan | CO-FOUNDER | 1,054 0.0008% | $165.87 | $174,827 | -0.93% | |
2025-01-29 | Sale | Chapman Steven Leonard | CEO AND PRESIDENT | 13,685 0.0102% | $165.87 | $2.27M | -0.93% | |
2025-01-29 | Sale | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | 4,773 0.0036% | $165.87 | $791,694 | -0.93% | |
2025-01-29 | Sale | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | 4,030 0.003% | $165.87 | $668,454 | -0.93% | |
2025-01-29 | Sale | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 5,201 0.0039% | $165.87 | $862,688 | -0.93% | |
2025-01-29 | Sale | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | 4,335 0.0032% | $165.87 | $719,044 | -0.93% | |
2025-01-27 | Sale | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | 1,442 0.0011% | $161.87 | $233,417 | +1.20% | |
2025-01-24 | Sale | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | 946 0.0007% | $171.98 | $162,689 | -0.39% |
Rabinowitz Matthew | EXECUTIVE CHAIRMAN | 2365415 1.7497% | $350.6M | 1 | 73 | +52.44% |
BOTHA ROELOF | director | 1224787 0.906% | $181.54M | 2 | 2 | +4.55% |
HEALY JAMES | director | 0 0% | $0 | 3 | 2 | <0.0001% |
Steuart John | director | 0 0% | $0 | 1 | 1 | <0.0001% |
$53,318,456 | 175 | 15.57% | $432.04M | |
$38,597,637 | 114 | 658.88% | $2.47M | |
$1,590,764 | 16 | 3.90% | $55.22M | |
Natera, Inc. (NTRA) | $26,663,659 | 7 | -12.13% | $20.04B |
$151,252 | 6 | -58.10% | $11.58M |
Increased Positions | 323 | +56.77% | 17M | +14% |
Decreased Positions | 256 | -44.99% | 13M | -10.88% |
New Positions | 137 | New | 3M | New |
Sold Out Positions | 43 | Sold Out | 579,247 | Sold Out |
Total Postitions | 636 | +11.78% | 127M | +3.12% |
Vanguard Group Inc | $1.92M | 9.33% | 12.32M | +879,463 | +7.69% | 2024-12-31 |
Blackrock, Inc. | $1.43M | 6.96% | 9.18M | +947,457 | +11.51% | 2024-12-31 |
Price T Rowe Associates Inc /Md/ | $1.05M | 5.11% | 6.74M | +4M | +134.88% | 2024-12-31 |
Jpmorgan Chase & Co | $1.04M | 5.08% | 6.7M | +2M | +44.68% | 2024-12-31 |
Farallon Capital Management Llc | $689,514.00 | 3.36% | 4.43M | -125,700 | -2.76% | 2024-12-31 |
Duquesne Family Office Llc | $554,966.00 | 2.7% | 3.57M | 0 | 0% | 2024-12-31 |
Wellington Management Group Llp | $504,118.00 | 2.46% | 3.24M | +439,778 | +15.71% | 2024-12-31 |
Fred Alger Management, Llc | $469,542.00 | 2.29% | 3.02M | -994,184 | -24.78% | 2024-12-31 |
State Street Corp | $465,365.00 | 2.27% | 2.99M | -503,369 | -14.4% | 2024-12-31 |
Rtw Investments, Lp | $403,495.00 | 1.97% | 2.59M | 0 | 0% | 2024-12-31 |